Last reviewed · How we verify
Absolute Bioavailability
At a glance
| Generic name | Absolute Bioavailability |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet (PHASE1)
- Effects of Carnitine Supplementation on Exercise-Induced Muscle Damage: A Randomized Controlled Trial (NA)
- A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body (PHASE1)
- A Study in Healthy Men to Test How BI 1584862 is Processed in the Body (PHASE1)
- A Study to Test How BI 1819479 is Taken up and Processed by the Body (PHASE1)
- A Study to Understand What the Body Does to the Study Medicine Called PF-07220060 When Taken by Healthy Adults (PHASE1)
- Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers (PHASE1)
- AZD5305 hADME in Patients With Advanced Solid Malignancies (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Absolute Bioavailability CI brief — competitive landscape report
- Absolute Bioavailability updates RSS · CI watch RSS
- Pfizer portfolio CI